Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,655 articlesInvestors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Redwire posted a strong revenue beat but a bigger-than-expected loss, triggering a mid-day rally in its stock. This a...
Sofi stocks have shown impressive momentum, but two big risks loom: a concentrated Galileo platform revenue stream an...
UBS is moving to absorb Credit Suisse, ending a years-long saga of espionage, talent raids, and legal clashes. The de...
NVIDIA is at the center of AI-driven growth, and the latest update from CEO Jensen Huang has investors buzzing. This ...
With the housing market cooling, investors are redirecting capital toward durable infrastructure plays. This report e...
Stocks wobble as a fresh batch of analyst notes lands on top names like Albemarle, American Express and CME Group. He...
Traders are shifting toward a data-driven approach to forex analysis as policy shifts and macro data reshape currency...
SpaceX's IPO headlines would be enormous and tempting. This article shares the one clear message I’d tell every inves...
When a sports contract becomes a financial puzzle, you learn what to watch for in any investment. This piece breaks d...
Navitas Semiconductor has ridden a wave of AI infrastructure enthusiasm as data-center spending strengthens. This art...
Tech stocks aren’t falling because of headlines about conflicts. The bigger driver is AI infrastructure capex and mac...